OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: A systematic review

World Journal of Pediatrics

Volumn 6, Issue 1, 2010, Pages 5-12

  Schaad, Urs B ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Children; immunostimulant; OM 85 Broncho Vaxom; Recurrent respiratory tract infections

Indexed keywords

BACTERIUM LYSATE; PLACEBO;

CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG WITHDRAWAL; GASTROINTESTINAL DISEASE; HUMAN; INFECTION RISK; META ANALYSIS; PEDIATRICS; POPULATION; RECURRENT INFECTION; RESPIRATORY TRACT INFECTION; REVIEW; SENSITIVITY ANALYSIS; SKIN MANIFESTATION; SYSTEMATIC REVIEW;

ADJUVANTS, IMMUNOLOGIC; BACTERIA; CELL EXTRACTS; CHILD; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RESPIRATORY TRACT INFECTIONS;

EID: 76749112026     PISSN: 17088569     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12519-010-0001-x     Document Type: Review

References (44)

1. A. Rozy J. Chorostowska-Wynimko 2008 Bacterial immunostimulants-mechanism of action and clinical application in respiratory diseases Pneumonol Alergol Pol 76 353 359 19003766
2. C. Zelle-Rieser R. Ramoner G. Bartsch M. Thurnher 2001 A clinically approved oral vaccine against pneumotropic bacteria induces the terminal maturation of CD83+ immunostimulatory dendritic cells Immunol Lett 76 63 67 10.1016/S0165-2478(00)00326-6 1:CAS:528:DC%2BD3MXht12gu74%3D 11222915 (Pubitemid 32166913)
3. B. Emmerich H.P. Emslander K. Pachmann M. Hallek D. Milatovic R. Busch 1990 Local immunity in patients with chronic bronchitis and the effects of a bacterial extract, Broncho-Vaxom, on T lymphocytes, macrophages, gamma-interferon and secretory immunoglobulin A in bronchoalveolar lavage fluid and other variables Respiration 57 90 99 10.1159/000195827 1:STN:280: DyaK3M%2Fkslartw%3D%3D 2122507
4. B. Emmerich K. Pachmann D. Milatovic H.P. Emslander 1992 Influence of OM-85-BV on different humoral and cellular immune defense mechanisms of the respiratory tract Respiration 59 Suppl3 19 23 10.1159/000196126 1439235
5. U.B. Schaad 2005 Prevention of paediatric respiratory tract infections: emphasis on the role of OM-85 Eur Respir Rev 14 74 77 10.1183/09059180.05. 00009506 (Pubitemid 43028776)
6. S. Illi E. von Mutius S. Lau R. Bergmann B. Niggemann C. Sommerfeld, et al. 2001 Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study BMJ 322 390 395 10.1136/bmj.322.7283.390 1:STN:280:DC%2BD3M7lvVeitg%3D%3D 11179155 (Pubitemid 32193268)
7. N. Pavia-Ruz P. Lopez J.I. Santos 1991 Recurrent respiratory infection in children: its clinical and laboratory evaluation Bol Med Hosp Infant Mex 48 385 397 1:STN:280:DyaK38%2FgtVakuw%3D%3D 1910553
8. E. von Mutius S. Illi T. Hirsch W. Leupold U. Keil S.K. Weiland 1999 Frequency of infections and risk of asthma, atopy and airway hyperresponsiveness in children Eur Respir J 14 4 11 10.1034/j.1399-3003.1999.14a03.x (Pubitemid 29411227)
9. B. Lina M. Valette S. Foray J. Luciani J. Stagnara D.M. See, et al. 1996 Surveillance of community-acquired viral infections due to respiratory viruses in Rhone-Alpes (France) during winter 1994 to 1995 J Clin Microbiol 34 3007 3011 1:STN:280:DyaK2s%2FpsFSiug%3D%3D 8940439
10. A. Lopez-Yap A. Abdelnour B. Lomonte O. Porras 2001 Serum antibody response to polysaccharides in children with recurrent respiratory tract infections Clin Diagn Lab Immunol 8 1012 1014 1:STN:280:DC%2BD3MvosFGgsg%3D%3D 11527819
11. U.B. Schaad R. Mutterlein H. Goffin 2002 Immunostimulation with OM-85-BV in children with recurrent infections of the upper respiratory tract: a double-blind, placebo-controlled multicenter study Chest 122 2042 2049 10.1378/chest.122.6.2042 12475845 (Pubitemid 36051142)
12. O.P. Alho M. Koivu M. Sorri P. Rantakallio 1990 Risk factors for recurrent acute otitis media and respiratory infection in infancy Int J Pediatr Otorhinolaryngol 19 151 161 10.1016/0165-5876(90)90221-C 1:STN:280: DyaK3czisVSitg%3D%3D 2373599 (Pubitemid 20195562)
13. J.B. van Woensel W.M. van Aalderen J.L. Kimpen 2003 Viral lower respiratory tract infection in infants and young children BMJ 327 36 40 10.1136/bmj.327.7405.36 12842956
14. B.E. Del-Rio-Navarro S. Gonzalez-Diaz A.J. Escalante-Dominguez V. Blandon-Vijil 2007 Immunostimulants in the prevention of respiratory infections Int J Biotechnol 9 246 260 10.1504/IJBT.2007.014245 (Pubitemid 47310016)
15. J.P. Collet J.P. Boissel 1994 OM-85 BV: primary versus secondary prevention Respiration 61 Suppl1 20 23 10.1159/000196376 7800967
16. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. (Available from: www.cochrane-handbook.org )
17. J. Ahrens M. Wiedenbach 1984 Efficacy of the immunostimulant Broncho-Vaxom Schweiz Med Wochenschr 114 932 934 1:STN:280:DyaL2c3nsVemtw%3D%3D 6379870
18. Z.G. Chen J.Z. Ji M. Li Y.F. Chen F.H. Chen H. Chen 2007 Immunoregulants improves the prognosis of infants with wheezing Nan Fang Yi Ke Da Xue Xue Bao 27 1612 1613 1:CAS:528:DC%2BD2sXhtlGqsbzI 17959549
19. J.P. Collet T. Ducruet M.S. Kramer J. Haggerty D. Floret J.J. Chomel, et al. 1993 Stimulation of nonspecific immunity to reduce the risk of recurrent infections in children attending day-care centers. The Epicreche Research Group Pediatr Infect Dis J 12 648 652 1:STN:280:DyaK2c%2FitFWgsQ%3D%3D 8414777
20. J. Field D. Gómez-Barreto B.E. Del-Rio-Navarro A. Berber 1998 Use of OM-85 BV in the primary prevention of acute respiratory tract infections in children in orphanages Cur Ther Res 59 407 418 10.1016/S0011-393X(98)85044-3 1:CAS:528:DyaK1cXksV2qtrw%3D (Pubitemid 28302761)
21. M.D. Gutiérrez-Tarango A. Berber 1997 Efficacy of a bacterial extract (OM-85 BV) in preventing recurrent respiratory tract infections in susceptible children Clin Drug Investig 13 76 84 10.2165/00044011-199713020- 00003 18370454
22. A. Kapellerova M. Sulko A. Krovinova M. Jakubovska J. Michalickova O. Mazarikova 1989 Immunologic indicators in the treatment of recurrent respiratory diseases using peroral bacterial vaccines Cesk Pediatr 44 454 458 1:STN:280:DyaK3c%2FgtlChug%3D%3D 2791096
23. G.J. Maestroni G.A. Losa 1984 Clinical and immunobiological effects of an orally administered bacterial extract Int J Immunopharmacol 6 111 117 10.1016/0192-0561(84)90005-5 1:STN:280:DyaL2c3jvVGhuw%3D%3D 6234240 (Pubitemid 14109021)
24. R.E. Martin du Pan R.C. Martin du Pan 1982 Clinical Study concerning the prevention of infections of the upper respiratory tract of preschool children Schweiz Rundsch Med Prax 71 1385 1389 1:STN:280:DyaL3s%2FjvFalsA%3D%3D 6752937
25. A. Quezada L. Maggi M.A. Perez J. Rodriguez 1999 Effect of bacterial antigen lysate on IgG and IgA levels in children with recurrent infections and hypogammaglobulinemia J Investig Allergol Clin Immunol 9 178 182 1:CAS:528:DyaK1MXltVWktL4%3D 10412680
26. S. Ziuzio B. Sakson 1994 Vaccine therapy in the treatment of nasal and sinus bacterial allergies Wiad Lek 47 510 513 1:STN:280:DyaK2M3jt12mtg%3D%3D 7716937
27. B.E. Del-Rio-Navarro J.J. Luis Sienra-Monge A. Berber S. Torres-Alcántara L. Avila-Castañón D. Gómez-Barreto 2003 Use of OM-85 BV in children suffering from recurrent respiratory tract infections and subnormal IgG subclass levels Allergol Immunopathol (Madr) 31 7 13 10.1157/13042838 1:STN:280:DC%2BD3s%2FmtlSisg%3D%3D (Pubitemid 36262336)
28. D. Gomez Barreto C. De la Torre A. Alvarez A. Faure A. Berber 1998 Safety and efficacy of OM-85-BV plus amoxicillin/clavulanate in the treatment of subacute sinusitis and the prevention of recurrent infections in children Allergol Immunopathol (Madr) 26 17 22 1:STN:280:DyaK1c3ks12itw%3D%3D
29. M.D. Gutiérrez-Tarango A. Berber 2001 Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months Chest 119 1742 1748 10.1378/chest.119.6.1742 11399700 (Pubitemid 32744931)
30. J.V. Jara-Perez A. Berber 2000 Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: a double-masked, placebo-controlled clinical trial Clin Ther 22 748 759 10.1016/S0149-2918(00) 90008-0 1:STN:280:DC%2BD3M%2FjslSqtw%3D%3D 10929921 (Pubitemid 30451999)
31. J. Paupe 1991 Immunotherapy with an oral bacterial extract (OM-85) for upper respiratory infections Respiration 58 150 154 10.1159/000195916 1:STN:280:DyaK38%2FotVygug%3D%3D 1745846
32. U.B. Schaad J.C. Farine T.H. Fux 1986 Prospective placebo-controlled double-blind study using a bacterial lysate in infections of the respiratory tract and ENT region in children Helv Paediatr Acta 41 7 17 1:STN:280: DyaL283ltVWntg%3D%3D 3755127
33. S. Zagar D. Löfler-Badzek 1988 Broncho-Vaxom in children with rhinosinusitis: a double-blind clinical trial ORL J Otorhinolaryngol Relat Spec 50 397 404 1:STN:280:DyaL1M7lvF2ktg%3D%3D 3068610
34. A.R. Jadad R.A. Moore D. Carroll C. Jenkinson D.J. Reynolds D.J. Gavaghan, et al. 1996 Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1 12 10.1016/0197-2456(95) 00134-4 1:STN:280:DyaK28zgvVCmug%3D%3D 8721797 (Pubitemid 26120810)
35. Bland M. An introduction to medical statistics. Oxford: Oxford Medical Publishing Ed., 1995: 235-238, 323-326.
36. Walfish S. A Review of Statistical Outlier Methods. Pharmaceutical Technology, 2006. http://pharmtech.findpharma.com/pharmtech/article/ articleDetail.jsp?id= 384716 (accessed July 8, 2008).
37. C. Steurer-Stey L. Lagler D.A. Straub J. Steurer L.M. Bachmann 2007 Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic quantitative review Eur J Pediatr 166 365 376 10.1007/s00431-006- 0248-3 17115184 (Pubitemid 46295095)
38. C. De la Torre González A. Pacheco Ríos A.J. Escalante Domínguez B.E. del Río Navarro 2005 Comparative meta-analysis of immunoestimulant agents used in pediatric patients in Mexico Rev Alerg Mex 52 25 38 15957470
39. Del-Rio-Navarro BE, Espinosa Rosales F, Flenady V, Sienra-Monge JJL. Immunostimulants for preventing respiratory tract infection in children. Cochrane Database Syst Rev 2006;(4): CD004974.
40. J. Barden S. Derry H. McQuay R. Moore 2006 Bias from industry trial funding? A framework, a suggested approach, and a negative result Pain 121 207 218 10.1016/j.pain.2005.12.011 16495012
41. L. Bero F. Oostvogel P. Bacchetti K. Lee 2007 Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others PLoS Med 4 e184 10.1371/journal.pmed.0040184 17550302 (Pubitemid 46998618)
42. A.W. Jørgensen J. Hilden P.C. Gøtzsche 2006 Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review BMJ 333 782 10.1136/bmj.38973.444699.0B 17028106 (Pubitemid 44583357)
43. J. LeLorier G. Grégoire A. Benhaddad J. Lapierre F. Derderian 1997 Discrepancies between meta-analyses and subsequent large randomized, controlled trials N Engl J Med 337 536 542 10.1056/NEJM199708213370806 1:STN:280:DyaK2szptVajtg%3D%3D 9262498 (Pubitemid 27352021)
44. J.P. Ioannidis J. Lau 2001 Evolution of treatment effects over time: empirical insight from recursive cumulative meta analyses PNAS 98 831 836 10.1073/pnas.021529998 1:CAS:528:DC%2BD3MXht1Snu74%3D 11158556 (Pubitemid 32121147)